NCT00632255View on ClinicalTrials.gov

Long Term Therapy With Imatinib: Development of Late Side Effects and Compliance to Treatment

CompletedOBSERVATIONAL

Enrollment

88

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions

Chronic Myeloid LeukemiaNewly Diagnosed

Interventions

DRUG

Imatinib

Conventional therapy with imatinib

Trial Locations (1)

W12 0HS

Haematology Department. Catherine Lewis Centre. Hammersmith Hospital. Du Cane Road., London

Sponsors

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Imperial College London

OTHER